[1]
Muhammad Khurram Shahzad et al. 2024. EXPLORING INTRAVENOUS NTCP AS A NOVEL THERAPEUTIC STRATEGY TO SUPPRESS HEPATITIS B VIRUS ENTRY AND INFECTION. Journal of Population Therapeutics and Clinical Pharmacology. 31, 9 (Sep. 2024), 3687–3693. DOI:https://doi.org/10.53555/9jb7dq08.